| Metric | FY 2020 | Prior Q | FY 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $54M | — | $40M | — | 36.7% |
| Op. Income | $7M | — | $10M | — | -30.1% |
| Gross Margin | 80.8% | — | 80.2% | — | 0.6pp |
| Net Margin | 8.7% | — | 17.1% | — | -8.4pp |
| EPS (Diluted) | $0.49 | — | $0.78 | — | -37.2% |
| Free Cash Flow | $11M | — | $7M | — | 47.8% |
| Item | Amount |
|---|---|
| REVENUE | $54M |
| Cost of Revenue | $10M |
| GROSS PROFIT | $44M |
| R&D Expenses | $0 |
| Selling & Marketing | $566.0K |
| General & Administrative | $22M |
| SG&A Expenses | $23M |
| Other Expenses | $14M |
| Operating Expenses | $37M |
| Cost & Expenses | $47M |
| OPERATING INCOME | $7M |
| Interest Income | $52M |
| Interest Expense | $6M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $1M |
| EBIT | $7M |
| EBITDA | $8M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $54M |
| Cost of Revenue | $10M |
| GROSS PROFIT | $44M |
| R&D Expenses | $0 |
| Selling & Marketing | $566.0K |
| General & Administrative | $22M |
| SG&A Expenses | $23M |
| Other Expenses | $14M |
| Operating Expenses | $37M |
| Cost & Expenses | $47M |
| OPERATING INCOME | $7M |
| Interest Income | $52M |
| Interest Expense | $6M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $7M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $5M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5M |
| D&A | $1M |
| EBIT | $7M |
| EBITDA | $8M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $5M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $3M |
| Deferred Income Tax | -$2M |
| Other Non-Cash Items | $5M |
| Change in Working Capital | $782.0K |
| OPERATING CASH FLOW | $12M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $37M |
| Purchases of Investments | -$14M |
| Sales/Maturities of Investments | $15M |
| Other Investing Activities | -$337M |
| NET CASH FROM INVESTING | -$302M |
| Net Debt Issuance | $126M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $282M |
| NET CASH FROM FINANCING | $449M |
| FREE CASH FLOW | $11M |
| Net Change in Cash | $160M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $12M |
| Short-Term Investments | $25M |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $37M |
| PP&E (Net) | $15M |
| Goodwill | $20M |
| Intangible Assets | $2M |
| Long-Term Investments | $1.2B |
| Tax Assets | $6M |
| Other Non-Current Assets | $276M |
| TOTAL NON-CURRENT ASSETS | $1.5B |
| TOTAL ASSETS | $1.6B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $1.2B |
| TOTAL CURRENT LIABILITIES | $1.2B |
| Long-Term Debt | $30M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $176M |
| TOTAL NON-CURRENT LIABILITIES | $215M |
| TOTAL LIABILITIES | $1.4B |
| Common Stock | $147M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $22M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $295.0K |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $169M |
| Minority Interest | $0 |
| TOTAL EQUITY | $169M |
| TOTAL LIABILITIES & EQUITY | $1.6B |
| Total Debt | $40M |
| Net Debt | $28M |
